SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-324514
Filing Date
2020-12-22
Accepted
2020-12-22 16:01:51
Documents
1
Group Members
NIALL O'DONNELLRIVERVEST VENTURE PARTNERS IV, L.P.RIVERVEST VENTURE PARTNERS IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d103425dsc13da.htm SC 13D/A 96331
  Complete submission text file 0001193125-20-324514.txt   97957
Mailing Address 101 SOUTH HANLEY ROAD, SUITE 1850 ST. LOUIS MO 63105
Business Address 101 SOUTH HANLEY ROAD, SUITE 1850 ST. LOUIS MO 63105 (314) 726-6700
RiverVest Venture Fund IV, L.P. (Filed by) CIK: 0001725443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91075 | Film No.: 201407983
SIC: 2834 Pharmaceutical Preparations